ovarian%20mass
OVARIAN MASS
Ovarian cysts are typically noted after clinical screening, or as a result of exam for a suspected pelvic mass, or an incidental finding in investigations done for other reasons.
Most ovarian masses manifest with few or mild nonspecific symptoms.
Ovarian masses in women of reproductive age are mostly benign but the risk of malignancy increases with age.
Ovarian cysts in the prepubertal patients especially after the first week of life are abnormal and likely to be neoplastic. In adolescent patients, majority of ovarian masses are functional cysts.

Introduction

  • Ovarian cysts in prepubertal patients especially after the first week of life are abnormal and likely to be neoplastic, prompt ultrasound (US) evaluation and referral are warranted 
  • In adolescent patients, majority of ovarian masses are functional cysts
    • The most common neoplastic ovarian tumor in this age group is benign cystic teratoma of the ovary
  • Ovarian mass in women of reproductive age is mostly benign but the risk of malignancy increases with age
    • In most adnexal masses, malignancy is found in only 7-13% of premenopausal and 8-45% of postmenopausal patients
    • Risk of malignancy for ovarian tumor in patients <45 years is <1 in 15 while in postmenopausal women, the figure is 50% at the time of laparotomy 

Signs and Symptoms

  • Most ovarian masses manifest with few or mild nonspecific symptoms
    • Common symptoms include abdominal distension, abdominal pain or discomfort, metrorrhagia, dyspareunia, infertility, lower abdominal pressure sensation and urinary or gastrointestinal (GI) symptoms
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 27 Dec 2018
A lifestyle intervention programme focusing on healthy habits was associated with weight loss and better disease-free survival (DFS) among early breast cancer survivors, according to the SUCCESS C* study presented at SABCS 2018.
23 Dec 2018
TX-001HR, a fixed-dose combination of oestradiol and progesterone, yields clinically meaningful improvements in the frequency and/or severity vasomotor symptoms in menopausal women with a uterus, according to a study.
22 Dec 2018
Breastfeeding for more than 6 months after birth appears to be independently associated with a long-term decrease in waist circumference, reports a recent study.
Elaine Soliven, 11 Jul 2018

Adding bevacizumab to platinum-based chemotherapy significantly improves progression-free survival (PFS) in patients with recurrent ovarian cancer who were previously treated with first-line bevacizumab, according to the MITO16B - MaNGO OV2B - ENGOT OV17* study presented at ASCO 2018.